Noriko Hattori

Noriko Hattori is an accomplished executive with extensive experience in corporate strategy, business development, and public health policy. Currently serving as Vice President at AstraZeneca since April 2025, Hattori also holds a board position at the French Chamber of Commerce and Industry in Japan. Prior to these roles, Hattori was Head of Strategic Program at Roche Diagnostics Japan and held several leadership positions within Roche related to Diabetes Care. Hattori's career also includes a tenure as Business Unit Director at Abbott and as GLP-1 brand lead at Novo Nordisk for Europe. Hattori earned an M.Sc. in Management from HEC Paris, where academic excellence was recognized through scholarships.